Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2011

Open Access 01-04-2011 | Original Article

Altered Gut Flora Are Associated with Septic Complications and Death in Critically Ill Patients with Systemic Inflammatory Response Syndrome

Authors: Kentaro Shimizu, Hiroshi Ogura, Toshimitsu Hamasaki, Miki Goto, Osamu Tasaki, Takashi Asahara, Koji Nomoto, Masami Morotomi, Asako Matsushima, Yasuyuki Kuwagata, Hisashi Sugimoto

Published in: Digestive Diseases and Sciences | Issue 4/2011

Login to get access

Abstract

Background

Gut under severe insult is considered to have an important role in promoting infection and multiple organ dysfunction syndrome from the viewpoint of altered intestinal epithelium, immune system and commensal bacteria. There are few reports, however, about the relationship between gut flora and septic complications.

Methods

We analyzed gut flora in patients with systemic inflammatory response syndrome (SIRS) and evaluated key bacteria and their cutoff values for infectious complications and mortality by using classification and regression trees (CART). Eighty-one SIRS patients with a serum C-reactive protein level higher than 10 mg/dL treated in the intensive care unit (ICU) for more than 2 days were included for the study. We quantitatively evaluated nine types of bacteria in fecal samples by plate or tube technique. Two hundred seventy-one samples were analyzed using CART and logistic regression.

Results

The dominant factors for complication of enteritis were the minimum number of total obligate anaerobes and the maximum number of Staphylococcus and Enterococcus. The dominant factors for complication of bacteremia were the minimum numbers of total obligate anaerobes and total facultative anaerobes. The dominant factors for mortality were the numbers of total obligate anaerobes and total facultative anaerobes and age.

Conclusions

A decrease in total obligate anaerobes and an increase in pathogenic bacteria in the gut are associated with septic complications and mortality in patients with SIRS. The altered gut flora may be a potential prognostic marker in SIRS patients.
Literature
2.
go back to reference Gill SR, Pop M, Deboy RT, et al. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312:1355–1359.PubMedCrossRef Gill SR, Pop M, Deboy RT, et al. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312:1355–1359.PubMedCrossRef
3.
go back to reference Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science. 2004;303:1662–1665.PubMedCrossRef Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science. 2004;303:1662–1665.PubMedCrossRef
4.
go back to reference Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004;118:229–241.PubMedCrossRef Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004;118:229–241.PubMedCrossRef
5.
go back to reference Hooper LV, Wong MH, Thelin A, et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science. 2001;291:881–884.PubMedCrossRef Hooper LV, Wong MH, Thelin A, et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science. 2001;291:881–884.PubMedCrossRef
6.
go back to reference Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr. 2000;30:61–67.PubMedCrossRef Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr. 2000;30:61–67.PubMedCrossRef
8.
go back to reference Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008;134:577–594.PubMedCrossRef Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008;134:577–594.PubMedCrossRef
9.
go back to reference Bjorksten B. Primary prevention of atopic asthma. Curr Opin Allergy Clin Immunol. 2001;1:545–548.PubMedCrossRef Bjorksten B. Primary prevention of atopic asthma. Curr Opin Allergy Clin Immunol. 2001;1:545–548.PubMedCrossRef
10.
go back to reference Ley RE, Turnbaugh PJ, Klein S, et al. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444:1022–1023.PubMedCrossRef Ley RE, Turnbaugh PJ, Klein S, et al. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444:1022–1023.PubMedCrossRef
11.
go back to reference Liu Q, Duan Z, Ha da K, et al. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology. 2004;39:1441–1449.PubMedCrossRef Liu Q, Duan Z, Ha da K, et al. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology. 2004;39:1441–1449.PubMedCrossRef
12.
go back to reference Kerckhoffs AP, Samsom M, van der Rest ME, et al. Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol. 2009;15:2887–2892.PubMedCrossRef Kerckhoffs AP, Samsom M, van der Rest ME, et al. Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol. 2009;15:2887–2892.PubMedCrossRef
13.
go back to reference Shimizu K, Ogura H, Goto M, et al. Altered gut flora and environment in patients with severe SIRS. J Trauma. 2006;60:126–133.PubMedCrossRef Shimizu K, Ogura H, Goto M, et al. Altered gut flora and environment in patients with severe SIRS. J Trauma. 2006;60:126–133.PubMedCrossRef
14.
go back to reference American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864-874. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864-874.
15.
go back to reference Azuma R, Suto T. Validity of transfer of the taxonomical position of Corynebacterium pseudopyogenes from genus Corynebacterium to genus Actinomyces. In: Izuka H, Hasegawa T, eds. Proceeding of the First International Conference on Culture Collection. Tokyo: University of Tokyo Press; 1970:493–505. Azuma R, Suto T. Validity of transfer of the taxonomical position of Corynebacterium pseudopyogenes from genus Corynebacterium to genus Actinomyces. In: Izuka H, Hasegawa T, eds. Proceeding of the First International Conference on Culture Collection. Tokyo: University of Tokyo Press; 1970:493–505.
16.
go back to reference Tanaka R, Mutai M. Improved medium for selective isolation and enumeration of Bifidobacterium. Appl Environ Microbiol. 1980;40:866–869.PubMed Tanaka R, Mutai M. Improved medium for selective isolation and enumeration of Bifidobacterium. Appl Environ Microbiol. 1980;40:866–869.PubMed
17.
go back to reference Petts DN. Colistin-oxolinic acid-blood agar: a new selective medium for streptococci. J Clin Microbiol. 1984;19:4–7.PubMed Petts DN. Colistin-oxolinic acid-blood agar: a new selective medium for streptococci. J Clin Microbiol. 1984;19:4–7.PubMed
18.
go back to reference Mitsuoka T, Ono K. Fecal flora of man V communication: the fluctuation of the fecal flora of the healthy adult (author’s transl). Zentralbl Bakteriol [OrigA]. 1977;238:228–236. Mitsuoka T, Ono K. Fecal flora of man V communication: the fluctuation of the fecal flora of the healthy adult (author’s transl). Zentralbl Bakteriol [OrigA]. 1977;238:228–236.
20.
go back to reference Breiman L, Friedman JF, Olshen RA, et al. Classification and Regression Trees. New York: Chapman & Hall; 1984. Breiman L, Friedman JF, Olshen RA, et al. Classification and Regression Trees. New York: Chapman & Hall; 1984.
21.
go back to reference Vollaard EJ, Clasener HA. Colonization resistance. Antimicrob Agents Chemother. 1994;38:409–414.PubMed Vollaard EJ, Clasener HA. Colonization resistance. Antimicrob Agents Chemother. 1994;38:409–414.PubMed
22.
go back to reference Steffen EK, Berg RD, Deitch EA. Comparison of translocation rates of various indigenous bacteria from the gastrointestinal tract to the mesenteric lymph node. J Infect Dis. 1988;157:1032–1038.PubMed Steffen EK, Berg RD, Deitch EA. Comparison of translocation rates of various indigenous bacteria from the gastrointestinal tract to the mesenteric lymph node. J Infect Dis. 1988;157:1032–1038.PubMed
23.
go back to reference O’Boyle CJ, MacFie J, Mitchell CJ, et al. Microbiology of bacterial translocation in humans. Gut. 1998;42:29–35.PubMedCrossRef O’Boyle CJ, MacFie J, Mitchell CJ, et al. Microbiology of bacterial translocation in humans. Gut. 1998;42:29–35.PubMedCrossRef
24.
go back to reference Danielle AW, Silva AB, Palmer DB. Immunosenescence: emerging challenges for an ageing population. Immunology. 2007;120:435–446.CrossRef Danielle AW, Silva AB, Palmer DB. Immunosenescence: emerging challenges for an ageing population. Immunology. 2007;120:435–446.CrossRef
26.
go back to reference Saltzman JR, Kowdley KV, Perrone G, et al. Changes in small-intestine permeability with aging. J Am Geriatr Soc. 1995;43:160–164.PubMed Saltzman JR, Kowdley KV, Perrone G, et al. Changes in small-intestine permeability with aging. J Am Geriatr Soc. 1995;43:160–164.PubMed
27.
go back to reference Ogier JC, Serror P. Safety assessment of dairy microorganisms: the Enterococcus genus. Int J Food Microbiol. 2008;126:291–301.PubMedCrossRef Ogier JC, Serror P. Safety assessment of dairy microorganisms: the Enterococcus genus. Int J Food Microbiol. 2008;126:291–301.PubMedCrossRef
Metadata
Title
Altered Gut Flora Are Associated with Septic Complications and Death in Critically Ill Patients with Systemic Inflammatory Response Syndrome
Authors
Kentaro Shimizu
Hiroshi Ogura
Toshimitsu Hamasaki
Miki Goto
Osamu Tasaki
Takashi Asahara
Koji Nomoto
Masami Morotomi
Asako Matsushima
Yasuyuki Kuwagata
Hisashi Sugimoto
Publication date
01-04-2011
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2011
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1418-8

Other articles of this Issue 4/2011

Digestive Diseases and Sciences 4/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.